TJ191
CAS No. 1522415-97-9
TJ191 ( —— )
Catalog No. M23656 CAS No. 1522415-97-9
TJ191 is a selective anti-cancer agent, targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 35 | In Stock |
|
5MG | 58 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 177 | In Stock |
|
50MG | 295 | In Stock |
|
100MG | 484 | In Stock |
|
500MG | 1035 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTJ191
-
NoteResearch use only, not for human use.
-
Brief DescriptionTJ191 is a selective anti-cancer agent, targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells.
-
DescriptionTJ191 is a selective anti-cancer agent, targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells.
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1522415-97-9
-
Formula Weight255.4
-
Molecular FormulaC13H21NO2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCCCCCCC1=CC(C(OC)=O)=C(N)S1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ahmed El-Gazzar, et al. 2-Amino-3-methylcarboxy-5-heptyl-thiophene (TJ191) is a selective anti-cancer small molecule that targets low TβRIII-expressing malignant T-cell leukemia/lymphoma cells. Oncotarget. 2017 Dec 15;9(5):6259-6269.
molnova catalog
related products
-
LYN-1604 dihydrochlo...
LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.
-
Batabulin
Batabulin is an antitumor compound, which binds covalently and selectively to a subset of the β-tubulin isotypes, thereby disrupting microtubule polymerization.
-
Bacopaside II
Bacopaside II is a potential anti-angiogenic agent, it can reduce endothelial cell migration and tubulogenesis and induce apoptosis.